Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Metastatic renal cell cancer treatments: an indirect comparison meta-analysis.

Mills EJ, Rachlis B, O'Regan C, Thabane L, Perri D.

BMC Cancer. 2009 Jan 27;9:34. doi: 10.1186/1471-2407-9-34. Review.

2.

Targeted therapy for metastatic renal cell carcinoma.

Motzer RJ, Bukowski RM.

J Clin Oncol. 2006 Dec 10;24(35):5601-8. Review.

PMID:
17158546
3.

Bevacizumab, sorafenib tosylate, sunitinib and temsirolimus for renal cell carcinoma: a systematic review and economic evaluation.

Thompson Coon J, Hoyle M, Green C, Liu Z, Welch K, Moxham T, Stein K.

Health Technol Assess. 2010 Jan;14(2):1-184, iii-iv. doi: 10.3310/hta14020. Review.

4.

Targeted therapies for the treatment of metastatic renal cell carcinoma: clinical evidence.

Hutson TE.

Oncologist. 2011;16 Suppl 2:14-22. doi: 10.1634/theoncologist.2011-S2-14. Review.

5.

First-line therapy for treatment-naive patients with advanced/metastatic renal cell carcinoma: a systematic review of published randomized controlled trials.

Takyar S, Diaz J, Sehgal M, Sapunar F, Pandha H.

Anticancer Drugs. 2016 Jun;27(5):383-97. doi: 10.1097/CAD.0000000000000335. Review.

PMID:
26886011
6.

Recent advances in the treatment of renal cell carcinoma and the role of targeted therapies.

Chowdhury S, Larkin JM, Gore ME.

Eur J Cancer. 2008 Oct;44(15):2152-61. doi: 10.1016/j.ejca.2008.06.028. Epub 2008 Sep 29. Review.

PMID:
18829302
7.

[Angiogenesis inhibitors for the systemic treatment of metastatic renal cell carcinoma: sunitinib, sorafenib, bevacizumab and temsirolimus].

de Mulder PH, Haanen JB, Sleijfer S, Kruit WH, Gietema JA, Richel DJ, Groenewegen G, Voest EE, van den Eertwegh AJ, Osanto S, Jansen RL, Mulders PF.

Ned Tijdschr Geneeskd. 2008 Feb 16;152(7):371-5. Review. Dutch.

PMID:
18380383
8.

Targeted treatment for metastatic renal cell carcinoma and immune regulation.

Laschos KA, Papazisis KT, Kontovinis LF, Kalaitzis C, Gianakopoulos S, Kortsaris AH, Touloupidis S.

J BUON. 2010 Apr-Jun;15(2):235-40. Review.

PMID:
20658715
9.

[Effect of angiogenesis inhibitors on renal cell carcinoma].

Bodrogi I.

Magy Onkol. 2007;51(2):145-53. Epub 2007 Jul 29. Review. Hungarian.

10.

[Angiogenesis inhibition: review of the activity of sorafenib, sunitinib and bevacizumab].

Barrascout E, Medioni J, Scotte F, Ayllon J, Mejean A, Cuenod CA, Tartour E, Elaidi R, Oudard S.

Bull Cancer. 2010;97:29-43. doi: 10.1684/bdc.2010.1068. Review. French.

PMID:
20418202
11.

New therapeutic approaches in the management of metastatic renal cell carcinoma.

Gkialas IK, Papadopoulos G.

J BUON. 2009 Jul-Sep;14(3):399-404. Review.

PMID:
19810129
12.

[Interdisciplinary recommendations for the treatment of metastatic renal cell carcinoma].

Miller K, Bergmann L, Jäger E, Jakse G, Wirth M, Keilholz U; interdisziplinäre Arbeitsgruppe Nierenzellkarzinom der Deutschen Krebsgesellschaft e.V. (DKG).

Aktuelle Urol. 2009 Jan;40(1):27-30. doi: 10.1055/s-0028-1098786. Epub 2009 Jan 28. German.

PMID:
19177318
13.
14.

Systemic therapy for metastatic renal cell carcinoma.

Kroog GS, Motzer RJ.

Urol Clin North Am. 2008 Nov;35(4):687-701; ix. doi: 10.1016/j.ucl.2008.07.007. Review.

PMID:
18992622
15.

Targeted therapies in metastatic renal cell carcinoma: the light at the end of the tunnel.

Pouessel D, Culine S.

Expert Rev Anticancer Ther. 2006 Dec;6(12):1761-7. Review.

PMID:
17181490
16.

Treatment options for metastatic renal cell carcinoma: a review.

Athar U, Gentile TC.

Can J Urol. 2008 Apr;15(2):3954-66. Review.

PMID:
18405442
17.

Progress in the management of advanced renal cell carcinoma (RCC).

Tong TQ, Rohde D, Peter S.

Aktuelle Urol. 2010 Jan;41 Suppl 1:S57-60. doi: 10.1055/s-0030-1247237. Epub 2010 Jan 21. Review.

PMID:
20094957
18.

Targeted therapies in metastatic renal cancer in 2009.

Bastien L, Culine S, Paule B, Ledbai S, Patard JJ, de la Taille A.

BJU Int. 2009 May;103(10):1334-42. doi: 10.1111/j.1464-410X.2009.08454.x. Epub 2009 Mar 11. Review.

19.

[Angiogenesis targeting in renal carcinomas].

Pouessel D, Culine S.

Bull Cancer. 2007;94(7 Suppl):F223-6. Review. French.

PMID:
17965000
20.

[Novelties in the treatment for advanced renal-cell cancer].

Maráz A.

Orv Hetil. 2011 Apr 24;152(17):655-62. doi: 10.1556/OH.2011.29100. Review. Hungarian.

PMID:
21464023

Supplemental Content

Support Center